Serveur d'exploration sur l'oranger

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Skin repair properties of d-Limonene and perillyl alcohol in murine models.

Identifieur interne : 000281 ( PubMed/Checkpoint ); précédent : 000280; suivant : 000282

Skin repair properties of d-Limonene and perillyl alcohol in murine models.

Auteurs : Patrizia A. D'Alessio ; Massoud Mirshahi ; Jean-Francois Bisson ; Marie C. Bene [France]

Source :

RBID : pubmed:24160248

English descriptors

Abstract

The orange-peel derived terpene d-Limonene, probably through its metabolite, perillyl alcohol (POH), has been reported to have tissue-repair properties. Two murine models of respectively 12-O-Tetradecanoylphorbol-13-Acetate (TPA)-induced dermatitis and mechanical skin lesion were used here to assess the efficacy of d-Limonene or POH applied topically. Macroscopic and microscopic evaluation of skin lesions was performed as well as that of P-selectin expression, together with measurements of serum concentrations of IL-1β, IL-6 and TNF-α in the first model. Healing and angiogenesis around the scar were examined in the second model. Because differences in angiogenesis were noted, the effect of both d-Limonene and POH was further tested on an in vitro model of endothelial microtubules formation. Both d-Limonene and POH reduced the severity and extension of TPA-induced skin lesions with significantly lowered macroscopic and microscopic scores (p<0.04 in both cases). Moreover, the expression of P-selectin induced by TPA was abrogated by POH and significantly lower serum concentrations of IL-6 and TNF-α were observed in d-Limonene- and POH-treated mice (p<0.04 and 0.03). In the second model, tissue regeneration was improved, especially by POH, and was clearly associated with reduced neovascularization. This surprising anti-angiogenic effect was confirmed in the matrigel model of endothelial microtubules formation. These studies show that d-Limonene and POH demonstrate significant anti-inflammatory effects in murine dermal inflammation and wound-healing. The decreased systemic cytokine production as well as a consistent inhibition of endothelial P-selectin expression and neo-vascularization induced by these terpenic compounds contribute to their healing effects on the epidermal barrier.

PubMed: 24160248


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24160248

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Skin repair properties of d-Limonene and perillyl alcohol in murine models.</title>
<author>
<name sortKey="D Alessio, Patrizia A" sort="D Alessio, Patrizia A" uniqKey="D Alessio P" first="Patrizia A" last="D'Alessio">Patrizia A. D'Alessio</name>
</author>
<author>
<name sortKey="Mirshahi, Massoud" sort="Mirshahi, Massoud" uniqKey="Mirshahi M" first="Massoud" last="Mirshahi">Massoud Mirshahi</name>
</author>
<author>
<name sortKey="Bisson, Jean Francois" sort="Bisson, Jean Francois" uniqKey="Bisson J" first="Jean-Francois" last="Bisson">Jean-Francois Bisson</name>
</author>
<author>
<name sortKey="Bene, Marie C" sort="Bene, Marie C" uniqKey="Bene M" first="Marie C" last="Bene">Marie C. Bene</name>
<affiliation wicri:level="1">
<nlm:affiliation>Biopark Campus Cancer, 1, mail Pr Georges Mathe, 94807 Villejuif - France. endocell@wanadoo.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24160248</idno>
<idno type="pmid">24160248</idno>
<idno type="wicri:Area/PubMed/Corpus">000358</idno>
<idno type="wicri:Area/PubMed/Curation">000358</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000358</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Skin repair properties of d-Limonene and perillyl alcohol in murine models.</title>
<author>
<name sortKey="D Alessio, Patrizia A" sort="D Alessio, Patrizia A" uniqKey="D Alessio P" first="Patrizia A" last="D'Alessio">Patrizia A. D'Alessio</name>
</author>
<author>
<name sortKey="Mirshahi, Massoud" sort="Mirshahi, Massoud" uniqKey="Mirshahi M" first="Massoud" last="Mirshahi">Massoud Mirshahi</name>
</author>
<author>
<name sortKey="Bisson, Jean Francois" sort="Bisson, Jean Francois" uniqKey="Bisson J" first="Jean-Francois" last="Bisson">Jean-Francois Bisson</name>
</author>
<author>
<name sortKey="Bene, Marie C" sort="Bene, Marie C" uniqKey="Bene M" first="Marie C" last="Bene">Marie C. Bene</name>
<affiliation wicri:level="1">
<nlm:affiliation>Biopark Campus Cancer, 1, mail Pr Georges Mathe, 94807 Villejuif - France. endocell@wanadoo.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Anti-inflammatory & anti-allergy agents in medicinal chemistry</title>
<idno type="eISSN">1875-614X</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Administration, Cutaneous</term>
<term>Angiogenesis Inhibitors (therapeutic use)</term>
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Citrus sinensis</term>
<term>Cyclohexenes (therapeutic use)</term>
<term>Cytokines (blood)</term>
<term>Dermatitis, Irritant (drug therapy)</term>
<term>Disease Models, Animal</term>
<term>Endothelium (drug effects)</term>
<term>Endothelium (pathology)</term>
<term>Female</term>
<term>Fruit</term>
<term>Gene Expression Regulation (drug effects)</term>
<term>Humans</term>
<term>Inflammation Mediators (blood)</term>
<term>Mice</term>
<term>Mice, Hairless</term>
<term>Microtubules (drug effects)</term>
<term>Monoterpenes (therapeutic use)</term>
<term>P-Selectin (metabolism)</term>
<term>Phorbol Esters (administration & dosage)</term>
<term>Phytotherapy</term>
<term>Skin (drug effects)</term>
<term>Skin (injuries)</term>
<term>Skin (pathology)</term>
<term>Terpenes (therapeutic use)</term>
<term>Wound Healing (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Phorbol Esters</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Cytokines</term>
<term>Inflammation Mediators</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>P-Selectin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Angiogenesis Inhibitors</term>
<term>Cyclohexenes</term>
<term>Monoterpenes</term>
<term>Terpenes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Endothelium</term>
<term>Gene Expression Regulation</term>
<term>Microtubules</term>
<term>Skin</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Dermatitis, Irritant</term>
</keywords>
<keywords scheme="MESH" qualifier="injuries" xml:lang="en">
<term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Endothelium</term>
<term>Skin</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Administration, Cutaneous</term>
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Citrus sinensis</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Fruit</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Hairless</term>
<term>Phytotherapy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The orange-peel derived terpene d-Limonene, probably through its metabolite, perillyl alcohol (POH), has been reported to have tissue-repair properties. Two murine models of respectively 12-O-Tetradecanoylphorbol-13-Acetate (TPA)-induced dermatitis and mechanical skin lesion were used here to assess the efficacy of d-Limonene or POH applied topically. Macroscopic and microscopic evaluation of skin lesions was performed as well as that of P-selectin expression, together with measurements of serum concentrations of IL-1β, IL-6 and TNF-α in the first model. Healing and angiogenesis around the scar were examined in the second model. Because differences in angiogenesis were noted, the effect of both d-Limonene and POH was further tested on an in vitro model of endothelial microtubules formation. Both d-Limonene and POH reduced the severity and extension of TPA-induced skin lesions with significantly lowered macroscopic and microscopic scores (p<0.04 in both cases). Moreover, the expression of P-selectin induced by TPA was abrogated by POH and significantly lower serum concentrations of IL-6 and TNF-α were observed in d-Limonene- and POH-treated mice (p<0.04 and 0.03). In the second model, tissue regeneration was improved, especially by POH, and was clearly associated with reduced neovascularization. This surprising anti-angiogenic effect was confirmed in the matrigel model of endothelial microtubules formation. These studies show that d-Limonene and POH demonstrate significant anti-inflammatory effects in murine dermal inflammation and wound-healing. The decreased systemic cytokine production as well as a consistent inhibition of endothelial P-selectin expression and neo-vascularization induced by these terpenic compounds contribute to their healing effects on the epidermal barrier.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24160248</PMID>
<DateCreated>
<Year>2014</Year>
<Month>2</Month>
<Day>3</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>8</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1875-614X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Anti-inflammatory & anti-allergy agents in medicinal chemistry</Title>
<ISOAbbreviation>Antiinflamm Antiallergy Agents Med Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Skin repair properties of d-Limonene and perillyl alcohol in murine models.</ArticleTitle>
<Pagination>
<MedlinePgn>29-35</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The orange-peel derived terpene d-Limonene, probably through its metabolite, perillyl alcohol (POH), has been reported to have tissue-repair properties. Two murine models of respectively 12-O-Tetradecanoylphorbol-13-Acetate (TPA)-induced dermatitis and mechanical skin lesion were used here to assess the efficacy of d-Limonene or POH applied topically. Macroscopic and microscopic evaluation of skin lesions was performed as well as that of P-selectin expression, together with measurements of serum concentrations of IL-1β, IL-6 and TNF-α in the first model. Healing and angiogenesis around the scar were examined in the second model. Because differences in angiogenesis were noted, the effect of both d-Limonene and POH was further tested on an in vitro model of endothelial microtubules formation. Both d-Limonene and POH reduced the severity and extension of TPA-induced skin lesions with significantly lowered macroscopic and microscopic scores (p<0.04 in both cases). Moreover, the expression of P-selectin induced by TPA was abrogated by POH and significantly lower serum concentrations of IL-6 and TNF-α were observed in d-Limonene- and POH-treated mice (p<0.04 and 0.03). In the second model, tissue regeneration was improved, especially by POH, and was clearly associated with reduced neovascularization. This surprising anti-angiogenic effect was confirmed in the matrigel model of endothelial microtubules formation. These studies show that d-Limonene and POH demonstrate significant anti-inflammatory effects in murine dermal inflammation and wound-healing. The decreased systemic cytokine production as well as a consistent inhibition of endothelial P-selectin expression and neo-vascularization induced by these terpenic compounds contribute to their healing effects on the epidermal barrier.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>d'Alessio</LastName>
<ForeName>Patrizia A</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mirshahi</LastName>
<ForeName>Massoud</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bisson</LastName>
<ForeName>Jean-Francois</ForeName>
<Initials>JF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bene</LastName>
<ForeName>Marie C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Biopark Campus Cancer, 1, mail Pr Georges Mathe, 94807 Villejuif - France. endocell@wanadoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ENG</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United Arab Emirates</Country>
<MedlineTA>Antiinflamm Antiallergy Agents Med Chem</MedlineTA>
<NlmUniqueID>101462262</NlmUniqueID>
<ISSNLinking>1871-5230</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020533">Angiogenesis Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053138">Cyclohexenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039821">Monoterpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019007">P-Selectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010703">Phorbol Esters</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013729">Terpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>319R5C7293</RegistryNumber>
<NameOfSubstance UI="C032208">perilla alcohol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9MC3I34447</RegistryNumber>
<NameOfSubstance UI="C008281">limonene</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000279" MajorTopicYN="N">Administration, Cutaneous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020533" MajorTopicYN="N">Angiogenesis Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D032084" MajorTopicYN="Y">Citrus sinensis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053138" MajorTopicYN="N">Cyclohexenes</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017453" MajorTopicYN="N">Dermatitis, Irritant</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004727" MajorTopicYN="N">Endothelium</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005638" MajorTopicYN="N">Fruit</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008812" MajorTopicYN="N">Mice, Hairless</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039821" MajorTopicYN="N">Monoterpenes</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019007" MajorTopicYN="N">P-Selectin</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010703" MajorTopicYN="N">Phorbol Esters</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008517" MajorTopicYN="Y">Phytotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013729" MajorTopicYN="N">Terpenes</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>7</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2013</Year>
<Month>10</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>10</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24160248</ArticleId>
<ArticleId IdType="pii">AIAAMC-EPUB-57007</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Bisson, Jean Francois" sort="Bisson, Jean Francois" uniqKey="Bisson J" first="Jean-Francois" last="Bisson">Jean-Francois Bisson</name>
<name sortKey="D Alessio, Patrizia A" sort="D Alessio, Patrizia A" uniqKey="D Alessio P" first="Patrizia A" last="D'Alessio">Patrizia A. D'Alessio</name>
<name sortKey="Mirshahi, Massoud" sort="Mirshahi, Massoud" uniqKey="Mirshahi M" first="Massoud" last="Mirshahi">Massoud Mirshahi</name>
</noCountry>
<country name="France">
<noRegion>
<name sortKey="Bene, Marie C" sort="Bene, Marie C" uniqKey="Bene M" first="Marie C" last="Bene">Marie C. Bene</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000281 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000281 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Bois
   |area=    OrangerV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24160248
   |texte=   Skin repair properties of d-Limonene and perillyl alcohol in murine models.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24160248" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a OrangerV1 

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 17:11:04 2016. Site generation: Wed Mar 6 18:18:32 2024